Tech Company Financing Transactions

Calithera Biosciences Funding Round

On 10/25/2013, Calithera Biosciences announced $35 million in Series D investment from Adage Capital Management, Advanced Technology Ventures and Delphi Ventures.

Transaction Overview

Company Name
Calithera Biosciences
Announced On
10/25/2013
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Series D
Investors

Adage Capital Management (Lead Investor)

Advanced Technology Ventures (Jean George)

Delphi Ventures (Deepa Pakianathan)

Longwood Fund

Morgenthaler Ventures (Ralph Christoffersen)

Proceeds Purpose
Calithera will use the proceeds from the financing to accelerate the development of the company's lead clinical-stage candidate CB-839 through Phase 1 clinical trials in patients with advanced solid and hematological tumors.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
343 Oyster Point Blvd. 200
San Francisco, CA 94080
USA
Phone
(650) 870-1000
Website
www.calithera.com
Email Address
[email protected]
Overview
Calithera is a pharmaceutical company developing novel small molecule therapeutics for the treatment of cancer.
Profile
Calithera Biosciences LinkedIn Company Profile
Social Media
Calithera Biosciences Company Twitter Account
Company News
Calithera Biosciences News
Facebook
Calithera Biosciences on Facebook
YouTube
Calithera Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Susan Molineaux
  Susan Molineaux LinkedIn Profile  Susan Molineaux Twitter Account  Susan Molineaux News  Susan Molineaux on Facebook
Vice President
Jennifer McNealey
  Jennifer McNealey LinkedIn Profile  Jennifer McNealey Twitter Account  Jennifer McNealey News  Jennifer McNealey on Facebook
Vice President
Keith Orford
  Keith Orford LinkedIn Profile  Keith Orford Twitter Account  Keith Orford News  Keith Orford on Facebook
Vice President
Eric Sjogren
  Eric Sjogren LinkedIn Profile  Eric Sjogren Twitter Account  Eric Sjogren News  Eric Sjogren on Facebook
Vice President
Sam Whiting
  Sam Whiting LinkedIn Profile  Sam Whiting Twitter Account  Sam Whiting News  Sam Whiting on Facebook
VP - Bus. Development
Curtis Hecht
  Curtis Hecht LinkedIn Profile  Curtis Hecht Twitter Account  Curtis Hecht News  Curtis Hecht on Facebook
VP - Bus. Development
Christopher Molineaux
  Christopher Molineaux LinkedIn Profile  Christopher Molineaux Twitter Account  Christopher Molineaux News  Christopher Molineaux on Facebook
VP - Finance
Stephanie Wong
  Stephanie Wong LinkedIn Profile  Stephanie Wong Twitter Account  Stephanie Wong News  Stephanie Wong on Facebook
VP - General Counsel
Sumita Ray
  Sumita Ray LinkedIn Profile  Sumita Ray Twitter Account  Sumita Ray News  Sumita Ray on Facebook
VP - R & D
Frank Parlati
  Frank Parlati LinkedIn Profile  Frank Parlati Twitter Account  Frank Parlati News  Frank Parlati on Facebook

 

 

Browse more venture capital transactions:

Prev: 10/25/2013: FeedVisor venture capital transaction
Next: 10/25/2013: Iris Mobile venture capital transaction

 

Share this article

 

About Database of VC Transactions

Our team works diligently to report on tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.